Momenta Pharmaceuticals, Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (19)

Latest Posts

About This Stock More About This Stock
Momenta Pharma - Chart Of The Day
Article By: Jim Van Meerten
Thursday, July 26, 2018 10:17 PM EDT
Momenta Pharmaceuticals is a leader in the analysis, characterization, and design of complex pharmaceutical products.
In this article: MNTA
Read
Drug Stocks Q4 Earnings Lineup For Feb 21: IRWD, MNTA, EXAS
Article By: Zacks Investment Research
Tuesday, February 21, 2017 4:30 AM EDT
Momenta’s bottom-line performance has been decent so far, with its earnings surpassing expectations in three of the last four quarters. However, over the trailing four quarters, the company has recorded an average negative surprise of 75.74%.
In this article: MNTA, EXAS, IRWD Also: ALXN, TEVA, ZTS
Read
EC HH 7 Drug Stocks To Consider As Biosimilars Pick Up Pace
Article By: Arpita Dutt
Thursday, October 20, 2016 1:53 PM EDT
Interest in biosimilars has picked up as Pfizer announced its plans to launch a biosimilar version of JNJ’s blockbuster drug, Remicade.
In this article: TEVA, BIIB, MNTA, MRK, NVS, AMGN, PFE
Read
Top Stock Stories At Midday: Oct. 11
Article By: The Fly
Tuesday, October 11, 2016 1:41 PM EDT
Stocks opened in negative territory following the worse than expected earnings and revenue reported by Alcoa (AA), which is traditionally seen as the company that "kicks off" earnings season for a given quarter.
In this article: AA, AAN, STJ, YUM, SSNLF, ILMN, MNTA, AAPL, RCII
Read
Biotech Investing Guide: 3 Stocks To Buy And 3 To Avoid
Article By: Arpita Dutt
Friday, March 11, 2016 2:10 PM EDT
Anyone interested in biotech stocks will know that it could be challenging to pick winners in this industry which is constantly growing and changing. We have zeroed in on 3 biotech stocks to buy and 3 to avoid.
In this article: ARNA, MNTA, REGN, AMGN, CELG, GILD Also: ABBV
Read

PARTNER HEADLINES

Latest Tweets for $MNTA

No tweets yet!